Oral Solid Dosage Pharmaceutical Formulation Market 2028 By Dosage Form, Drug Release Mechanism, Distribution Channel and Geography | The Insight Partners
Oral Solid Dosage Pharmaceutical Formulation Market Forecast to 2028 - Covid-19 Impact and Global Analysis - By Dosage Form (Tablets, Capsules, Powders, Others); Drug Release Mechanism (Immediate Release, Extended Release, Others); Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Drug Stores, Online Pharmacy); and Geography
Oral solid dosage pharmaceutical formulation is the primary procedure for the drug manufacturing companies. The solid form of the medicine is the easy way to consume the right dosage for various chronic and acute diseases. Formulating oral dosage form of medicine is cost effective and easy to manufacture and hence offer significant benefits to the manufacturers.
MARKET DYNAMICS
The oral solid dosage pharmaceutical formulation market is anticipated to grow in the forecast, owing to the factors such as increasing prevalence of diseases, advantages owing to the use of oral drugs, advances and innovations in the drugs, and easy availability of the drugs. The market is expected to have growth opportunities due to rising incidences of the chronic and acute diseases. Also, the growing generic pharmaceutical is likely to enhance the growth of the market.
MARKET SCOPE
The "Global Oral Solid Dosage Pharmaceutical Formulation Market Analysis to 2028" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of oral solid dosage pharmaceutical formulation market with detailed market segmentation by dosage form, drug release mechanism, distribution channel and geography. The global oral solid dosage pharmaceutical formulation market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading oral solid dosage pharmaceutical formulation market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The global oral solid dosage pharmaceutical formulation market is segmented on the basis of dosage form, drug release mechanism and distribution channel. Based on dosage the market is segmented into tablets, capsules, powders, and others. Based on drug release mechanism the market is segmented into immediate release, extended release, and others. Based on distribution channel the market is segmented into hospital pharmacy, retail pharmacy, drug stores, and online pharmacy.
Get more information on this report :
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global oral solid dosage pharmaceutical formulation market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The oral solid dosage pharmaceutical formulation market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting oral solid dosage pharmaceutical formulation market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Oral solid dosage pharmaceutical formulation market in these regions.
Get more information on this report :
MARKET PLAYERS
The reports cover key developments in the oral solid dosage pharmaceutical formulation market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from oral solid dosage pharmaceutical formulation market are anticipated to lucrative growth opportunities in the future with the rising demand for oral solid dosage pharmaceutical formulation market in the global market. Below mentioned is the list of few companies engaged in the oral solid dosage pharmaceutical formulation market.
The report also includes the profiles of oral solid dosage pharmaceutical formulation market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
Merck Co and Inc.
Novartis AG
Pfizer Inc
Bayer AG
Astellas Pharma Inc
Takeda Pharmaceutical Company Limited
Ashland
CordenPharma International
Acme Generics LLP
COREALIS Pharma Inc
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
Get more information on this report :
TABLE OF CONTENTS
1. INTRODUCTION 1.1. SCOPE OF THE STUDY 1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE 1.3. MARKET SEGMENTATION 1.3.1 Oral Solid Dosage Pharmaceutical Formulation Market - By Dosage Form 1.3.2 Oral Solid Dosage Pharmaceutical Formulation Market - By Drug Release Mechanism 1.3.3 Oral Solid Dosage Pharmaceutical Formulation Market - By Distribution Channel 1.3.4 Oral Solid Dosage Pharmaceutical Formulation Market - By Region 1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. ORAL SOLID DOSAGE PHARMACEUTICAL FORMULATION MARKET LANDSCAPE 4.1. OVERVIEW 4.2. PEST ANALYSIS 4.2.1 North America - Pest Analysis 4.2.2 Europe - Pest Analysis 4.2.3 Asia-Pacific - Pest Analysis 4.2.4 Middle East and Africa - Pest Analysis 4.2.5 South and Central America - Pest Analysis 4.3. EXPERT OPINIONS
6. ORAL SOLID DOSAGE PHARMACEUTICAL FORMULATION MARKET - GLOBAL MARKET ANALYSIS 6.1. ORAL SOLID DOSAGE PHARMACEUTICAL FORMULATION - GLOBAL MARKET OVERVIEW 6.2. ORAL SOLID DOSAGE PHARMACEUTICAL FORMULATION - GLOBAL MARKET AND FORECAST TO 2028 6.3. MARKET POSITIONING/MARKET SHARE
7. ORAL SOLID DOSAGE PHARMACEUTICAL FORMULATION MARKET - REVENUE AND FORECASTS TO 2028 - DOSAGE FORM 7.1. OVERVIEW 7.2. DOSAGE FORM MARKET FORECASTS AND ANALYSIS 7.3. TABLETS 7.3.1. Overview 7.3.2. Tablets Market Forecast and Analysis 7.4. CAPSULES 7.4.1. Overview 7.4.2. Capsules Market Forecast and Analysis 7.5. POWDERS 7.5.1. Overview 7.5.2. Powders Market Forecast and Analysis 7.6. OTHERS 7.6.1. Overview 7.6.2. Others Market Forecast and Analysis
8. ORAL SOLID DOSAGE PHARMACEUTICAL FORMULATION MARKET - REVENUE AND FORECASTS TO 2028 - DRUG RELEASE MECHANISM 8.1. OVERVIEW 8.2. DRUG RELEASE MECHANISM MARKET FORECASTS AND ANALYSIS 8.3. IMMEDIATE RELEASE 8.3.1. Overview 8.3.2. Immediate Release Market Forecast and Analysis 8.4. EXTENDED RELEASE 8.4.1. Overview 8.4.2. Extended Release Market Forecast and Analysis 8.5. OTHERS 8.5.1. Overview 8.5.2. Others Market Forecast and Analysis
9. ORAL SOLID DOSAGE PHARMACEUTICAL FORMULATION MARKET - REVENUE AND FORECASTS TO 2028 - DISTRIBUTION CHANNEL 9.1. OVERVIEW 9.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS 9.3. HOSPITAL PHARMACY 9.3.1. Overview 9.3.2. Hospital Pharmacy Market Forecast and Analysis 9.4. RETAIL PHARMACY 9.4.1. Overview 9.4.2. Retail Pharmacy Market Forecast and Analysis 9.5. DRUG STORES 9.5.1. Overview 9.5.2. Drug Stores Market Forecast and Analysis 9.6. ONLINE PHARMACY. 9.6.1. Overview 9.6.2. Online Pharmacy. Market Forecast and Analysis
10. ORAL SOLID DOSAGE PHARMACEUTICAL FORMULATION MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS 10.1. NORTH AMERICA 10.1.1 North America Oral Solid Dosage Pharmaceutical Formulation Market Overview 10.1.2 North America Oral Solid Dosage Pharmaceutical Formulation Market Forecasts and Analysis 10.1.3 North America Oral Solid Dosage Pharmaceutical Formulation Market Forecasts and Analysis - By Dosage Form 10.1.4 North America Oral Solid Dosage Pharmaceutical Formulation Market Forecasts and Analysis - By Drug Release Mechanism 10.1.5 North America Oral Solid Dosage Pharmaceutical Formulation Market Forecasts and Analysis - By Distribution Channel 10.1.6 North America Oral Solid Dosage Pharmaceutical Formulation Market Forecasts and Analysis - By Countries 10.1.6.1 United States Oral Solid Dosage Pharmaceutical Formulation Market 10.1.6.1.1 United States Oral Solid Dosage Pharmaceutical Formulation Market by Dosage Form 10.1.6.1.2 United States Oral Solid Dosage Pharmaceutical Formulation Market by Drug Release Mechanism 10.1.6.1.3 United States Oral Solid Dosage Pharmaceutical Formulation Market by Distribution Channel 10.1.6.2 Canada Oral Solid Dosage Pharmaceutical Formulation Market 10.1.6.2.1 Canada Oral Solid Dosage Pharmaceutical Formulation Market by Dosage Form 10.1.6.2.2 Canada Oral Solid Dosage Pharmaceutical Formulation Market by Drug Release Mechanism 10.1.6.2.3 Canada Oral Solid Dosage Pharmaceutical Formulation Market by Distribution Channel 10.1.6.3 Mexico Oral Solid Dosage Pharmaceutical Formulation Market 10.1.6.3.1 Mexico Oral Solid Dosage Pharmaceutical Formulation Market by Dosage Form 10.1.6.3.2 Mexico Oral Solid Dosage Pharmaceutical Formulation Market by Drug Release Mechanism 10.1.6.3.3 Mexico Oral Solid Dosage Pharmaceutical Formulation Market by Distribution Channel 10.2. EUROPE 10.2.1 Europe Oral Solid Dosage Pharmaceutical Formulation Market Overview 10.2.2 Europe Oral Solid Dosage Pharmaceutical Formulation Market Forecasts and Analysis 10.2.3 Europe Oral Solid Dosage Pharmaceutical Formulation Market Forecasts and Analysis - By Dosage Form 10.2.4 Europe Oral Solid Dosage Pharmaceutical Formulation Market Forecasts and Analysis - By Drug Release Mechanism 10.2.5 Europe Oral Solid Dosage Pharmaceutical Formulation Market Forecasts and Analysis - By Distribution Channel 10.2.6 Europe Oral Solid Dosage Pharmaceutical Formulation Market Forecasts and Analysis - By Countries 10.2.6.1 Germany Oral Solid Dosage Pharmaceutical Formulation Market 10.2.6.1.1 Germany Oral Solid Dosage Pharmaceutical Formulation Market by Dosage Form 10.2.6.1.2 Germany Oral Solid Dosage Pharmaceutical Formulation Market by Drug Release Mechanism 10.2.6.1.3 Germany Oral Solid Dosage Pharmaceutical Formulation Market by Distribution Channel 10.2.6.2 France Oral Solid Dosage Pharmaceutical Formulation Market 10.2.6.2.1 France Oral Solid Dosage Pharmaceutical Formulation Market by Dosage Form 10.2.6.2.2 France Oral Solid Dosage Pharmaceutical Formulation Market by Drug Release Mechanism 10.2.6.2.3 France Oral Solid Dosage Pharmaceutical Formulation Market by Distribution Channel 10.2.6.3 Italy Oral Solid Dosage Pharmaceutical Formulation Market 10.2.6.3.1 Italy Oral Solid Dosage Pharmaceutical Formulation Market by Dosage Form 10.2.6.3.2 Italy Oral Solid Dosage Pharmaceutical Formulation Market by Drug Release Mechanism 10.2.6.3.3 Italy Oral Solid Dosage Pharmaceutical Formulation Market by Distribution Channel 10.2.6.4 Spain Oral Solid Dosage Pharmaceutical Formulation Market 10.2.6.4.1 Spain Oral Solid Dosage Pharmaceutical Formulation Market by Dosage Form 10.2.6.4.2 Spain Oral Solid Dosage Pharmaceutical Formulation Market by Drug Release Mechanism 10.2.6.4.3 Spain Oral Solid Dosage Pharmaceutical Formulation Market by Distribution Channel 10.2.6.5 United Kingdom Oral Solid Dosage Pharmaceutical Formulation Market 10.2.6.5.1 United Kingdom Oral Solid Dosage Pharmaceutical Formulation Market by Dosage Form 10.2.6.5.2 United Kingdom Oral Solid Dosage Pharmaceutical Formulation Market by Drug Release Mechanism 10.2.6.5.3 United Kingdom Oral Solid Dosage Pharmaceutical Formulation Market by Distribution Channel 10.3. ASIA-PACIFIC 10.3.1 Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Market Overview 10.3.2 Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Market Forecasts and Analysis 10.3.3 Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Market Forecasts and Analysis - By Dosage Form 10.3.4 Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Market Forecasts and Analysis - By Drug Release Mechanism 10.3.5 Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Market Forecasts and Analysis - By Distribution Channel 10.3.6 Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Market Forecasts and Analysis - By Countries 10.3.6.1 Australia Oral Solid Dosage Pharmaceutical Formulation Market 10.3.6.1.1 Australia Oral Solid Dosage Pharmaceutical Formulation Market by Dosage Form 10.3.6.1.2 Australia Oral Solid Dosage Pharmaceutical Formulation Market by Drug Release Mechanism 10.3.6.1.3 Australia Oral Solid Dosage Pharmaceutical Formulation Market by Distribution Channel 10.3.6.2 China Oral Solid Dosage Pharmaceutical Formulation Market 10.3.6.2.1 China Oral Solid Dosage Pharmaceutical Formulation Market by Dosage Form 10.3.6.2.2 China Oral Solid Dosage Pharmaceutical Formulation Market by Drug Release Mechanism 10.3.6.2.3 China Oral Solid Dosage Pharmaceutical Formulation Market by Distribution Channel 10.3.6.3 India Oral Solid Dosage Pharmaceutical Formulation Market 10.3.6.3.1 India Oral Solid Dosage Pharmaceutical Formulation Market by Dosage Form 10.3.6.3.2 India Oral Solid Dosage Pharmaceutical Formulation Market by Drug Release Mechanism 10.3.6.3.3 India Oral Solid Dosage Pharmaceutical Formulation Market by Distribution Channel 10.3.6.4 Japan Oral Solid Dosage Pharmaceutical Formulation Market 10.3.6.4.1 Japan Oral Solid Dosage Pharmaceutical Formulation Market by Dosage Form 10.3.6.4.2 Japan Oral Solid Dosage Pharmaceutical Formulation Market by Drug Release Mechanism 10.3.6.4.3 Japan Oral Solid Dosage Pharmaceutical Formulation Market by Distribution Channel 10.3.6.5 South Korea Oral Solid Dosage Pharmaceutical Formulation Market 10.3.6.5.1 South Korea Oral Solid Dosage Pharmaceutical Formulation Market by Dosage Form 10.3.6.5.2 South Korea Oral Solid Dosage Pharmaceutical Formulation Market by Drug Release Mechanism 10.3.6.5.3 South Korea Oral Solid Dosage Pharmaceutical Formulation Market by Distribution Channel 10.4. MIDDLE EAST AND AFRICA 10.4.1 Middle East and Africa Oral Solid Dosage Pharmaceutical Formulation Market Overview 10.4.2 Middle East and Africa Oral Solid Dosage Pharmaceutical Formulation Market Forecasts and Analysis 10.4.3 Middle East and Africa Oral Solid Dosage Pharmaceutical Formulation Market Forecasts and Analysis - By Dosage Form 10.4.4 Middle East and Africa Oral Solid Dosage Pharmaceutical Formulation Market Forecasts and Analysis - By Drug Release Mechanism 10.4.5 Middle East and Africa Oral Solid Dosage Pharmaceutical Formulation Market Forecasts and Analysis - By Distribution Channel 10.4.6 Middle East and Africa Oral Solid Dosage Pharmaceutical Formulation Market Forecasts and Analysis - By Countries 10.4.6.1 South Africa Oral Solid Dosage Pharmaceutical Formulation Market 10.4.6.1.1 South Africa Oral Solid Dosage Pharmaceutical Formulation Market by Dosage Form 10.4.6.1.2 South Africa Oral Solid Dosage Pharmaceutical Formulation Market by Drug Release Mechanism 10.4.6.1.3 South Africa Oral Solid Dosage Pharmaceutical Formulation Market by Distribution Channel 10.4.6.2 Saudi Arabia Oral Solid Dosage Pharmaceutical Formulation Market 10.4.6.2.1 Saudi Arabia Oral Solid Dosage Pharmaceutical Formulation Market by Dosage Form 10.4.6.2.2 Saudi Arabia Oral Solid Dosage Pharmaceutical Formulation Market by Drug Release Mechanism 10.4.6.2.3 Saudi Arabia Oral Solid Dosage Pharmaceutical Formulation Market by Distribution Channel 10.4.6.3 U.A.E Oral Solid Dosage Pharmaceutical Formulation Market 10.4.6.3.1 U.A.E Oral Solid Dosage Pharmaceutical Formulation Market by Dosage Form 10.4.6.3.2 U.A.E Oral Solid Dosage Pharmaceutical Formulation Market by Drug Release Mechanism 10.4.6.3.3 U.A.E Oral Solid Dosage Pharmaceutical Formulation Market by Distribution Channel 10.5. SOUTH AND CENTRAL AMERICA 10.5.1 South and Central America Oral Solid Dosage Pharmaceutical Formulation Market Overview 10.5.2 South and Central America Oral Solid Dosage Pharmaceutical Formulation Market Forecasts and Analysis 10.5.3 South and Central America Oral Solid Dosage Pharmaceutical Formulation Market Forecasts and Analysis - By Dosage Form 10.5.4 South and Central America Oral Solid Dosage Pharmaceutical Formulation Market Forecasts and Analysis - By Drug Release Mechanism 10.5.5 South and Central America Oral Solid Dosage Pharmaceutical Formulation Market Forecasts and Analysis - By Distribution Channel 10.5.6 South and Central America Oral Solid Dosage Pharmaceutical Formulation Market Forecasts and Analysis - By Countries 10.5.6.1 Brazil Oral Solid Dosage Pharmaceutical Formulation Market 10.5.6.1.1 Brazil Oral Solid Dosage Pharmaceutical Formulation Market by Dosage Form 10.5.6.1.2 Brazil Oral Solid Dosage Pharmaceutical Formulation Market by Drug Release Mechanism 10.5.6.1.3 Brazil Oral Solid Dosage Pharmaceutical Formulation Market by Distribution Channel 10.5.6.2 Argentina Oral Solid Dosage Pharmaceutical Formulation Market 10.5.6.2.1 Argentina Oral Solid Dosage Pharmaceutical Formulation Market by Dosage Form 10.5.6.2.2 Argentina Oral Solid Dosage Pharmaceutical Formulation Market by Drug Release Mechanism 10.5.6.2.3 Argentina Oral Solid Dosage Pharmaceutical Formulation Market by Distribution Channel
11. INDUSTRY LANDSCAPE 11.1. MERGERS AND ACQUISITIONS 11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES 11.3. NEW PRODUCT LAUNCHES 11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. ORAL SOLID DOSAGE PHARMACEUTICAL FORMULATION MARKET, KEY COMPANY PROFILES 12.1. MERCK CO. And INC. 12.1.1. Key Facts 12.1.2. Business Description 12.1.3. Products and Services 12.1.4. Financial Overview 12.1.5. SWOT Analysis 12.1.6. Key Developments 12.2. NOVARTIS AG 12.2.1. Key Facts 12.2.2. Business Description 12.2.3. Products and Services 12.2.4. Financial Overview 12.2.5. SWOT Analysis 12.2.6. Key Developments 12.3. PFIZER INC 12.3.1. Key Facts 12.3.2. Business Description 12.3.3. Products and Services 12.3.4. Financial Overview 12.3.5. SWOT Analysis 12.3.6. Key Developments 12.4. BAYER AG 12.4.1. Key Facts 12.4.2. Business Description 12.4.3. Products and Services 12.4.4. Financial Overview 12.4.5. SWOT Analysis 12.4.6. Key Developments 12.5. ASTELLAS PHARMA INC 12.5.1. Key Facts 12.5.2. Business Description 12.5.3. Products and Services 12.5.4. Financial Overview 12.5.5. SWOT Analysis 12.5.6. Key Developments 12.6. TAKEDA PHARMACEUTICAL COMPANY LIMITED 12.6.1. Key Facts 12.6.2. Business Description 12.6.3. Products and Services 12.6.4. Financial Overview 12.6.5. SWOT Analysis 12.6.6. Key Developments 12.7. ASHLAND 12.7.1. Key Facts 12.7.2. Business Description 12.7.3. Products and Services 12.7.4. Financial Overview 12.7.5. SWOT Analysis 12.7.6. Key Developments 12.8. CORDENPHARMA INTERNATIONAL 12.8.1. Key Facts 12.8.2. Business Description 12.8.3. Products and Services 12.8.4. Financial Overview 12.8.5. SWOT Analysis 12.8.6. Key Developments 12.9. ACME GENERICS LLP 12.9.1. Key Facts 12.9.2. Business Description 12.9.3. Products and Services 12.9.4. Financial Overview 12.9.5. SWOT Analysis 12.9.6. Key Developments 12.10. COREALIS PHARMA INC 12.10.1. Key Facts 12.10.2. Business Description 12.10.3. Products and Services 12.10.4. Financial Overview 12.10.5. SWOT Analysis 12.10.6. Key Developments
13. APPENDIX 13.1. ABOUT THE INSIGHT PARTNERS 13.2. GLOSSARY OF TERMS
The List of Companies
1. Merck Co and Inc.2. Novartis AG3. Pfizer Inc4. Bayer AG5. Astellas Pharma Inc6. Takeda Pharmaceutical Company Limited7. Ashland8. CordenPharma International9. Acme Generics LLP10. COREALIS Pharma Inc
Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.